Identification of novel markers for neuroblastoma immunoclustering using machine learning
BATF, CXCR3, GIMAP5, GPR18, ISG20, and IGHM may serve as biomarkers that reflect the conditions of the immune microenvironment of neuroblastoma and hold promise in guiding neuroblastoma treatment.
Authors
- Feifei Sun (ORCID: https://orcid.org/0000-0001-9539-1451)
- Longguo Zhang (ORCID: https://orcid.org/0000-0002-7884-4081)
- Qiuping Wu (ORCID: https://orcid.org/0000-0002-8584-7598)
- Jiarui Chen (ORCID: https://orcid.org/0000-0002-5533-8434)
- Leigang Jin (ORCID: https://orcid.org/0000-0002-6916-4009)
- Ranyao Yang (ORCID: https://orcid.org/0000-0002-2957-3254)
- Aimin Xu
- Huixin Li (ORCID: https://orcid.org/0000-0003-2163-2253)
Institutions
- Sun Yat-sen University (CN)
- Jining First People's Hospital (CN)
- Shandong First Medical University (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.3389/fimmu.2024.1446273
- Citations
- 2
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.74